
Jaguar Health (NASDAQ:JAGX) brought in sales totaling $2.62 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 26.86%, resulting in a loss of $18.16 million. Jaguar Health collected $2.08 million in revenue during Q4, but reported earnings showed a $14.32 million loss.